Strix
26.1K

CVE-2011-3386

UnknownEPSS 1.45%

Last modified

CVE-2011-3386 is a vulnerability of currently unknown severity. Unspecified vulnerability in Medtronic Paradigm wireless insulin pump 512, 522, 712, and 722 allows remote attackers to modify the delivery of an insulin bolus dose and cause a denial of service (adverse human health effects) via unspecified vectors involving wireless communications and knowledge of the device's serial number, as demonstrated by Jerome Radcliffe at the Black Hat USA conference in August 2011. NOTE: the vendor has disputed the severity of this issue, saying "we believe the risk of deliberate, malicious, or unauthorized manipulation of medical devices is extremely low... EPSS estimates a 1.45% chance of exploitation in the next 30 days.

Description

Unspecified vulnerability in Medtronic Paradigm wireless insulin pump 512, 522, 712, and 722 allows remote attackers to modify the delivery of an insulin bolus dose and cause a denial of service (adverse human health effects) via unspecified vectors involving wireless communications and knowledge of the device's serial number, as demonstrated by Jerome Radcliffe at the Black Hat USA conference in August 2011. NOTE: the vendor has disputed the severity of this issue, saying "we believe the risk of deliberate, malicious, or unauthorized manipulation of medical devices is extremely low... we strongly believe it would be extremely difficult for a third-party to wirelessly tamper with your insulin pump... you would be able to detect tones on the insulin pump that weren't intentionally programmed and could intervene accordingly."

Metrics

EPSS Probability
1.45%

70.0th percentile

Probability of exploitation in the next 30 days. Learn more

Affected Software

VendorProductVersions
MedtronicParadigm Wireless Insulin Pump512
MedtronicParadigm Wireless Insulin Pump522
MedtronicParadigm Wireless Insulin Pump712
MedtronicParadigm Wireless Insulin Pump722

References

Timeline

Published
Last Modified
Status
Modified

Frequently Asked Questions

What is CVE-2011-3386?
Unspecified vulnerability in Medtronic Paradigm wireless insulin pump 512, 522, 712, and 722 allows remote attackers to modify the delivery of an insulin bolus dose and cause a denial of service (adverse human health effects) via unspecified vectors involving wireless communications and knowledge of the device's serial number, as demonstrated by Jerome Radcliffe at the Black Hat USA conference in August 2011. NOTE: the vendor has disputed the severity of this issue, saying "we believe the risk of deliberate, malicious, or unauthorized manipulation of medical devices is extremely low... we strongly believe it would be extremely difficult for a third-party to wirelessly tamper with your insulin pump... you would be able to detect tones on the insulin pump that weren't intentionally programmed and could intervene accordingly."
How severe is CVE-2011-3386?
Severity scoring for CVE-2011-3386 is pending analysis. The EPSS model estimates a 1.45% probability of exploitation in the next 30 days.
How do I fix CVE-2011-3386?
Check the vendor references and advisories linked above for patched versions and mitigation guidance. You can also run a Strix scan to test if your systems are affected.

How Strix Helps

Related CVEs from 2011

View all 2011CVEs →

Are you affected by CVE-2011-3386?

Run a free Strix scan to check your systems for this vulnerability.

Scan your code now

Source: NVD / NIST